Marshall Wace’s Tiziana Life Sciences TLSA Stock Holding History

Marshall Wace’s Portfolio TLSA Stock Details TLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-157,566	Closed	-$184K	–	3752
2026 Q1	$184K	Sell	157,566 -124,451	-44%	-$176K	﹤0.01%	2802
2025 Q4	$420K	Buy	282,017 +14,005	+5%	+$25.2K	﹤0.01%	2314
2025 Q3	$579K	Buy	268,012 +243,643	+1,000%	+$451K	﹤0.01%	2175
2025 Q2	$38.5K	Buy	+24,369	New	+$32.6K	﹤0.01%	2613
2021 Q4	–	Sell	-41,463	Closed	-$61K	–	4274
2021 Q3	$61K	Sell	41,463 -72,925	-64%	-$135K	﹤0.01%	2926
2021 Q2	$268K	Sell	114,388 -72,083	-39%	-$178K	﹤0.01%	2363
2021 Q1	$517K	Buy	+186,471	New	+$619K	﹤0.01%	1925

Other funds holding TLSA

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

MAWAG

Mid-American Wealth Advisory Group Kansas City, Missouri $277M AUM 6.22% 1-Year Est. Return

Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace's TLSA Position: Q2 2026 in Review

Marshall Wace sold out of Tiziana Life Sciences (TLSA) in Q2 2026, closing a stake of 157,566 shares — an estimated $184K sold.

Marshall Wace first reported a position in TLSA in Q1 2021 and held it in 7 quarters. The position peaked at $579K in Q3 2025. 30 funds tracked by Wall St. Rank hold TLSA as of Q2 2026.

Marshall Wace reported no remaining Tiziana Life Sciences position as of Q2 2026 after selling out during the quarter.
Marshall Wace sold 157,566 Tiziana Life Sciences shares in Q2 2026, an estimated $184K.
Marshall Wace first reported a position in Tiziana Life Sciences in Q1 2021 and held it in 7 quarters.
Marshall Wace's Tiziana Life Sciences position peaked at $579K in Q3 2025.
30 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.